Summary
The effect of antipsychotic drugs was tested on responses to micro-electrophoretically applied dopamine, acetylcholine and 5-hydroxy-tryptamine in identified neurons of the marine gastropod Aplysia californica. Fluphenazine was able to depress the response to DA in concentration of 10μM, with 100μM DA-responses of many neurons were blocked completely. Thioridazine (10 and 100μM) and haloperidol (50μM) were also effective in depressing DA-responses, while the non-antipsychotic phenothiazines mepazine (10 and 100μM) and promethazine (100μM) had only a slight action on DA-receptors. ACh-and 5-HT-responses were slightly affected only by high concentrations after long lasting perfusion. The investigated drugs had no persistent or only an insignificant effect on resting membrane potential and amplitude of action potentials of the neurons. With haloperidol depolarizing afterpotentials leading to double discharges were observed in some neurons. In a few instances spontaneous EPSPs disappeared with the DA-response under the influence of anti-psychotic drugs.
The results render a direct neurophysiological evidence for the blockade of DA-receptors by antipsychotic drugs in correspondence to their clinical efficacy and agree with data from clinical observations and obtained in neurochemical, behavioral and indirect neurophysiological experiments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol.11, 303–314 (1970).
Andén, N.-E., Corrodi, H., Fuxe, K., Ungerstedt, U.: Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Europ. J. Pharmacol.15, 193–199 (1971).
Andén, N.-E., Dahlström, A., Fuxe, K., Hökfelt, T.: The effect of haloperidol and chlorpromazine on the amine levels of central monoamine neurones. Acta physiol. scand.68, 419–420 (1966).
Ascher, P.: Inhibitory and excitatory effects of dopamine on Aplysia neurones. J. Physiol.225, 173–209 (1972).
Ayd, F. J.: A survey of drug-induced extrapyramidal reaction. J. Amer. med. Ass.175, 1054–1060 (1961).
Besson, M. J., Cheramy, A., Glowinski, J.: Effects of some psychotropic drugs on dopamine synthesis in the rat striatum. J. Pharmacol. Exp. Therap.177, 196–205 (1971).
Brown, J. H., Makman, M. H.: Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina. J. Neurochem.21, 477–479 (1973).
Bunney, B. S., Aghajanian, G. K.: Evidence for drug actions on both pre-and postsynaptic catecholamine receptors in the CNS. In: Pre-and Postsynaptic Receptors (Usdin, E., Bunney, W. E., eds.), Modern Pharmacology-Toxicology, Vol. 3, pp. 89–120. New York: M. Dekker. 1975.
Bunney, B. S., Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Therap.185, 560–571 (1973).
Carlsson, A., Lindqvist, M.: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta pharmacol. et toxicol.20, 140–144 (1963).
Cole, J. O., Clyde, D. J.: Extrapyramidal side effects and clinical response to the phenothiazines. Rev. can. Biol.20, 565–574 (1961).
Dahl, E., Falck, B., von Mecklemburg, C., Myhrberg, H., Rosengren, E.: Neuronal localization of dopamine and 5-hydroxytryptamine in some molluscs. Z. Zellforsch.71, 489–498 (1966).
Faber, D. S., Klee, M. R.: Strychnine interactions with acetylcholine, dopamine and serotonine receptors in Aplysia neurons. Brain Res.65, 109–126 (1974).
Faber, D. S., Klee, M. R., Heiss, W,-D.: Interaction of strychnine with acetylcholine and dopamine receptors in Aplysia neurones. XXV. Int. Congr. Physiol. Sci. Munich9, 167 (1971).
Feltz, D.: Sensitivity to haloperidol of caudate neurones excited by nigral stimulation. Europ. J. Pharmacol.14, 360–364 (1971).
Frazier, W. T., Kandel, E. R., Kupfermann, I., Waziri, R., Coggeshall, R. E.: Morphological and functional properties of identified neurons in the abdominal ganglion of Aplysia californica. J. Neurophysiol.30, 1288 to 1351 (1967).
Gerschenfeld, H. M.: Chemical transmission in invertebrate central nervous systems and neuromuscular junctions. Physiol. Rev.53, 1–119 (1973).
Gerschenfeld, H. M., Stefani, E.: An electrophysiological study of 5-hydroxytryptamine receptors of neurones in the moluscan nervous system. J. Physiol.185, 684–700 (1966).
Gey, K. F., Pletscher, A.: Acceleration of turnover of14C-catecholamines in rat brain by chlorpromazine. Experientia24, 335–336 (1968).
Gruener, R., Narahashi, T.: The mechanism of excitability blockade by chlorpromazine. J. Pharmacol. Exp. Therap.181, 161–170 (1972).
Haase, H. J., Janssen, P. A. J.: The Action of Neuroleptic Drugs. Amsterdam: North Holland. 1965.
Heiss, W.-D., Hoyer, J., Heilig, P.: Die Wirkung von Psychopharmaka auf visuell evozierte Potentiale der Katze. Vision Res.9, 507–513 (1969).
Hille, B.: Common mode of action of three agents that decrease the transient change in sodium permeability in nerves. Nature210, 1220 to 1222 (1966).
Hökfelt, J., Ljungdahl, A., Fuxe, K., Johansson, O.: Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science184, 177–179 (1974).
Horn, A. S., Post, M. L., Kennard, O.: Dopamine receptor blockade and the neuroleptics, a crystallographic study. J. Pharm. Pharmac.27, 553 to 563 (1975).
Horn, A. S., Snyder, S. H.: Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc. Nat. Acad. Sci. U.S.A.68, 2325–2328 (1971).
Hornykiewicz, O.: Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev.18, 925–964 (1966).
Hoyer, J., Klee, M. R., Heiss, W.-D.: Voltage clamp analysis of the action of a benzodiazepine on neurons in Aplysia californica. In: Physiology of the Gastropod Brain (Salánki, J., ed.). Budapest: Akadémiai Kiadó. 1976 (in press).
Iversen, L. L.: Dopamine receptors in the brain. Science188, 1084–1089 (1975).
Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., Lanaerts, F. M.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part IV: An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamineor apomorphine-induced “clawing and agitation” in rats. Arzneimitt.-Forsch. (Drug Res.)17, 841–854 (1967).
Kandel, E. R., Kupfermann, I.: The functional organization of invertebrate ganglia. Ann. Rev. Physiol.32, 193–258 (1970).
Karobath, M., Leitich, H.: Antipsychotic drugs and dopamine stimulated adenylate cyclase prepaired from corpus striatum of rat brain. Proc. Nat. Acad. Sci. U.S.A.71, 2915–2918 (1974).
Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”. Proc. Nat. Acad. Sci. U.S.A.69, 2145–2149 (1972).
Kehoe, J. S.: Three acethylcholine receptors in Aplysia neurones. J. Physiol.225, 115–146 (1972).
Klee, M. R., Faber, D. S., Heiss, W.-D.: Strychnine-and pentylenetetrazol-induced changes of excitability in Aplysia neurons. Science179, 1133 to 1136 (1973).
Klee, M. R., Heiss, W.-D.: Strychnine effects on cell membrane properties. Electroenceph. clin. Neurophysiol.27, 683–684 (1969).
Lemberger, L., Witt, E. D., Davis, J. M., Kopin, I. J.: The effects of haloperidol and chlorpromazine on amphetamine metabolism and amphetamine stereotype behavior in the rat. J. Pharmacol. Exp. Therap.174, 428–433 (1970).
Matthysse, St.: Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Federation Proc.32, 200–205 (1973).
Miller, R., Hiley, R.: Antimuscarinic actions of neuroleptic drugs. In: Dopaminergic Mechanisms (Calne, D., Chase, T. N., Barbeau, A., eds.), Advances in Neurology, Vol. 9, pp. 141–154. New York: Raven Press. 1975.
Miller, R. J., Horn, A. S., Iversen, L. L.: The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′, 5′-monophosphate production in rat neostriatum and limbic forebrain. Mol. Pharmacol.10, 759–766 (1974).
Nybäck, H., Borzecki, Z., Sedvall, G.: Accumulation and disappearance of catecholamines formed from tyrosme-14C in mouse brain; effect of some psychotropic drugs. Europ. J. Pharmacol.4, 395–403 (1968).
O'Keeffe, R., Sharman, D. F., Vogt, M.: Effects of drugs used in psychoses on cerebral dopamine metabolism. Br. J. Pharmacol.38, 287–304 (1970).
Da Prada, M., Pletscher, A.: Acceleration of the cerebral dopamine turnover by chlorpromazine. Experientia22, 465–466 (1966).
Sedvall, G., Fyrö, B., Nybäck, H., Wiesel, F. A.: Actions of dopaminergic antagonists in the striatum. In: Dopaminergic Mechanisms (Calne, D., Chase, T. N., Barbeau, A., eds.), Advances in Neurology, Vol. 9, pp. 131–140. New York: Raven Press. 1975.
Seeman, P., Lee, T.: Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science188, 1217–1219 (1975).
Seeman, P., Staiman, A., Chan-Wong, M.: The nerve impulse-blocking actions of tranquillizers and the binding of neuroleptics to synaptosome membranes. J. Pharmacol. Exp. Therap.190, 123–130 (1974).
Snyder, S. H.: Catecholamines in the brain as mediators of amphetamine psychosis. Arch. Gen. Psychiat.27, 169–179 (1972).
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., Grennberg, D.: Drugs, neurotransmitters and schizophrenia. Science184, 1243–1253 (1974).
Sweeney, D.: Dopamine: its occurrence in molluscan ganglia. Science139, 1051 (1963).
Tauc, L.: Physiology of the nervous system. In: Physiology of Molluscs (Wilbur, K. M., Yonge, C. M., eds.), Vol. I, pp. 387–454. New York: Academic Press. 1966.
Tauc, L.: Transmission in invertebrate and vertebrate ganglia. Physiol. Rev.47, 521–593 (1967).
Thierry, A. M., Stinus, L., Blanc, G., Glowinski, J.: Some evidence for the existence of dopaminergic neurones in the rat cortex. Brain Res.,50, 230–234 (1973).
Walker, R. J., Woodruff, G. N., Glaizner, D., Sedden, C. B., Kerkut, G. A.: The pharmacology of Helix dopamine receptors of specific neurones in the snail Helix aspera. Comp. Biochem. Physiol.24, 453–469 (1968).
Willows, A. O. D.: Gastropod nervous system as a model experimental system in neurobiological research. Federation Proc.32, 2215–2223 (1973).
Woodruff, G. N., Walker, R. J., Kerkut, G. A.: Actions of ergometrine on catecholamine receptors in the guinea-pig vas deferens and in the snail brain. Comp. gen. Pharmac.1, 54–60 (1970).
York, D. H.: Dopamine receptor blockade—a central action of chlorpromazine on striatal neurones. Brain Res.37, 91–99 (1972).
Author information
Authors and Affiliations
Additional information
Supported by the österreichischen Fonds zur Förderung der wissenschaftlichen Forschung. —A preliminary report of a part of the results was published in Experientia30, 1318–1320 (1974).
Rights and permissions
About this article
Cite this article
Heiss, W.D., Hoyer, J. & Thalhammer, G. Antipsychotic drugs and dopamine-mediated responses in Aplysia neurons. J. Neural Transmission 39, 187–208 (1976). https://doi.org/10.1007/BF01256509
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01256509